HPLC methods for clinical pharmaceutical analysis (Titelsatznr. 52793)

[ MARC ]
000 -LEADER
fixed length control field 03369nam a22003497a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20150712005503.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120430s2012 gw a b 001 0 eng d
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 015904442
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527331291
040 ## - CATALOGING SOURCE
Original cataloging agency BTCTA
Language of cataloging eng
Transcribing agency BTCTA
Modifying agency UKMGB
-- YDXCP
-- CDX
-- BDX
-- VGM
-- OHX
-- DLC
042 ## - AUTHENTICATION CODE
Authentication code lccopycat
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Item number M H
072 #7 - SUBJECT CATEGORY CODE
Subject category code R
Source lcco
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1901
084 ## - OTHER CLASSIFICATION NUMBER
Classification number 615.1901
Item number M H
001 - CONTROL NUMBER
control field 0000086968
003 - CONTROL NUMBER IDENTIFIER
control field 0000
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mascher, Hermann.
245 10 - TITLE STATEMENT
Title HPLC methods for clinical pharmaceutical analysis
Medium [[Book] :]
Remainder of title a user's guide /
Statement of responsibility, etc. Hermann Mascher.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Weinheim :
Name of publisher, distributor, etc. Wiley-VCH,
Date of publication, distribution, etc. c2012.
300 ## - PHYSICAL DESCRIPTION
Extent ix, 247 p. :
Other physical details ill. ;
Dimensions 25 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1.Introduction -- 1.1.First Question: Determination of Ibuprofen in Plasma -- 1.2.Second Question: Determination of Tryptophan in Urine -- 1.3.Third Question: Determination of Paclitaxel in Tissue -- 2.Planning of Analyses -- 2.1.Introduction -- 2.2.Limit of Detection (LOD) and Determination (LLOQ) -- 2.3.Detectors -- 2.4.Structure of the Analyte -- 2.5.Solubility of an Analyte -- 2.6.Selection of the Detector -- 3.Sample Preparation -- 3.1.Dilution -- 3.2.Protein Precipitation, Overview -- 3.3.Extraction -- 4.HPLC Separation -- 4.1.HPLC Pumps -- 4.2.Degasser -- 4.3.Injector -- 4.4.HPLC Columns -- 5.Detection -- 5.1.Detection in the Pharmaceutical/Bioanalytical Area -- 5.2.Detection in the "Clinical Area" (Therapy Control/Compliance) -- 6.Chemical Derivatization for Detection Enhancement -- 7.Validation Concepts -- 7.1.Introduction -- 7.2.Realization of the FDA Guideline -- 8.Practical Hints Concerning Stability, Destruction and Degradation Products -- 9.Metabolites -- 10.Internal Standards -- 11.Case Studies with Intensive Discussion for Each Substance -- 11.1.Acetylcarnitine in Plasma -- 11.2.Acetylcysteine in Plasma -- 11.3.Acyclovir in Plasma and Urine -- 11.4.Caffeine in Plasma -- 11.5.Diazepam in Plasma -- 11.6.Diclofenac in Plasma -- 11.7.Dihydralazine in Plasma -- 11.8.Duramycin (Moli1901) in Plasma -- 11.9.Fluticasone Propionate in Plasma -- 11.10.Hydroxytriamterene Sulfate and Triamterene in Plasma and Urine -- 11.11.Ibuprofen in Plasma (also Enantiomeric Separation) -- 11.12.Minocycline in Plasma -- 11.13.Norfloxacine in Plasma and Urine -- 11.14.Paclitaxel in Plasma, Urine and Tissue -- 11.15.Paracetamol (Acetaminophen) in Plasma -- 11.16.Pimelic Acid in Plasma and Urine -- 11.17.8-Prenylnaringenin in Plasma and Different Types of Tissues -- 11.18.Silibinin in Plasma -- 11.19.Valnemulin in Plasma, Different Tissue Types and in Animal Feed -- 11.20.Vitamin B1 (Total Thiamine) in Plasma -- Table 11.1 Recommended books -- Table 11.2 Properties of substances -- Appendix -- Short Description of Determination for about 100 Substances -- Substances listed in the Appendix.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element High performance liquid chromatography.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Analysis.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical technology.
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Contributor biographical information
Uniform Resource Identifier http://www.loc.gov/catdir/enhancements/fy1210/2012392592-b.html
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Publisher description
Uniform Resource Identifier http://www.loc.gov/catdir/enhancements/fy1210/2012392592-d.html
856 41 - ELECTRONIC LOCATION AND ACCESS
Materials specified Table of contents only
Uniform Resource Identifier http://www.loc.gov/catdir/enhancements/fy1210/2012392592-t.html
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Books
Exemplare
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Date last checked out Copy number Price effective from Koha item type
        6october 6october 1104 2013-03-07 479.00 1 615.1901 M H SOULE104006190 2021-11-22 2017-10-18 1 2015-07-12 Books
www.soul.o6u.edu.eg

E-Mail: soul@o6u.edu.eg
Address: October 6 city – Central Axis – Next to El Hosary mosque.
Tell: (+202) 38376382
Fax: (+202) 38376280



Developed and implemented by ILC EG